CDKN2A and glioblastoma: However, our results showed that neither SPTA1 (p=0.764) nor CAPZA2 (p=0.213) had significant associations with survival in patients with GBM after adjusting for age, gender, and CDK4(A)/RB1/CDKN2A(D).